Machine Learning News and Research

RSS

Interpretable framework to investigate the spatial organization of cells

In cells that are similar in form and function throughout tissues and organs, genes that are activated and expressed produce patterns. Identifying these patterns increases the understanding of cells, which could lead to the discovery of disease mechanisms.

18 Jan 2023

Optibrium appoints Steve Yemm as Chief Commercial Officer

New role will lead global commercial strategy and development as Optibrium continues to scale its drug discovery technologies and team.

From Optibrium Ltd. 17 Jan 2023

New open-access database provides a map of the proteome signature

The recently released cancer protein profile database, which was created using AI and machine learning, has helped with cancer prediction medicine. The new open-access Disease Blood Atlas, unveiled by KTH Royal Institute of Technology Professor Mathias Uhlén, gives the first-ever map of the proteome signature in cancer patients’ blood.

11 Jan 2023

Investigating the molecular mechanisms that govern cilia force sensing

Although the human body is superficially symmetric along the left–right axis, most internal organs, including the heart, lungs, liver, stomach, and brain, have noteworthy left–right asymmetries in their structure and placement.

6 Jan 2023

The link between tandem repeats and development of Schizophrenia

Each human cell is distinct because it is written in the DNA language.

1 Dec 2022

Bats use distinct laryngeal structures to generate echolocation and social calls

Bats use distinct structures in the larynx to produce high-frequency echolocation calls and lower-frequency social calls, according to a study by Coen Elemans at the University of Southern Denmark and colleagues, publishing November 29th in the open access journal PLOS Biology.

30 Nov 2022

Optibrium appoints Ian Smith as Chief Technology Officer

Optibrium, a leading developer of software and AI solutions for drug discovery, today announced the appointment of Ian Smith as Chief Technology Officer (CTO), the latest in a number of senior-level hires for the Company.

From Optibrium Ltd. 23 Nov 2022

New guidelines for genomic consent benefit patients and researchers

How can Canada maximize the benefits of human genomic sequencing to deepen knowledge of disease? For researchers and decision-makers in this expanding field, new guidance published in CMAJ (Canadian Medical Association Journal) establishes the essential components for obtaining patient consent.

16 Nov 2022

Rapid fluctuations in electrical activity within breast cancer cells identified

Recent research has discovered that the membranes of breast cancer cells have varying voltages, revealing information regarding their growth and spread.

15 Nov 2022

Novel proteomics approach to identify a three-protein signature in the blood

A new proteomics method has been utilized by researchers to determine a three-protein signature in the blood that has the potential to enhance the detection of separated impaired glucose tolerance, a form of prediabetes.

14 Nov 2022

Different cancers carry distinctive genetic signatures

After analyzing data from a public repository, CD4-T, CD8-T cells, and Treg cells, a team of researchers led by bioinformatics Mabel Vidal from the University of Concepcion and working with researchers from MELISA Institute and other academic institutions discovered a distinctive genetic signature among subsets of infiltrating T cells of various types of cancer.

4 Nov 2022

Quantifying microanatomical tissue structures without human intervention

Scientists at Weill Cornell Medicine have created a computational method for mapping the architecture of human tissues in extraordinary detail. Their method guarantees to expedite research on organ-scale cellular interactions and could lead to strong new diagnostic strategies for a variety of disorders.

1 Nov 2022

“Deep fake” protein created with AI to tackle water pollutants

If text-based artificial intelligence image generator like Craiyon or DALL-E has ever been used, it would lead to the knowledge of lifelike, yet entirely, synthetic visuals that AI tools produce.

21 Oct 2022

Applying machine learning to define significant immune cells

The method correctly categorizes macrophage states, which is crucial since these cells can alter their behavior and function as either pro- or anti-inflammatory agents during an immune response.

20 Oct 2022

Machine learning can predict the biological properties of Earth's most abundant enzyme

A Newcastle University study has for the first time shown that machine learning can predict the biological properties of the most abundant enzyme on Earth - Rubisco.

From Newcastle University 3 Oct 2022

Rutgers researchers seek to develop technology for protein editing

Rutgers researchers are seeking to develop the technology to modify or "edit" protein molecules in the body-;an advance that could spur major breakthroughs in human health.

From Rutgers University 26 Sep 2022

Researchers claim AI could produce protein molecules

Machine learning has completely changed protein structure prediction over the past two years. A comparable revolution in protein design is now described in three studies published in Science.

16 Sep 2022

Unique combination of transcription factors trigger cell regeneration in zebrafish

Scientists at the National Institutes of Health have identified a particular protein network required for cell regeneration to restore hearing in zebrafish.

From National Human Genome Research Institute (NHGRI) 15 Sep 2022

Cedars-Sinai builds bio-realistic and intricate computer models of brain cells

Researchers at Cedars-Sinai have produced an unprecedented number of bio-realistic and intricate computer models of individual brain cells.

11 Aug 2022

Researchers identify key molecular differences between initial and metastatic tumors

Researchers at Johns Hopkins Medicine claim to have discovered significant molecular variations between cancer cells that adhere to an initial tumor and those that spread out to develop distant tumors while researching the fatal form of breast cancer known as triple negative.

9 Aug 2022